Overview

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Status:
Completed

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The open label study is designed to assess the safety and efficacy of 0.05% PEP005 Gel when applied to an area of skin containing 4-8 AK lesions on non-head locations.

Phase:

Phase 3

Details

Lead Sponsor:

Peplin

Collaborator:

TKL Research, Inc.